Citation: | YU Yun, YU Hui, FENG Jing, SHEN Fei, YU Bin, CHEN Qing, SHI Le, BIAN Yong. Research on the Therapeutic Mechanism of Sargentgloryvine Stem on CIA Rats Based on NF-κB/NLRP3 Pathway[J]. Journal of Nanjing University of traditional Chinese Medicine, 2021, 37(3): 396-399. doi: 10.14148/j.issn.1672-0482.2021.0396 |
[1] |
WANG D, CHANG Y, WU Y, et al. Therapeutic effects of TACI-Ig on rat with adjuvant arthritis[J]. Clin Exp Immunol, 2011, 163(2): 225-234. doi: 10.1111/j.1365-2249.2010.04293.x
|
[2] |
倪士峰, 傅承新, 吴平. 大血藤化学成分及药学研究进展[J]. 中国野生植物资源, 2004, 23(4): 8-10. doi: 10.3969/j.issn.1006-9690.2004.04.003
|
[3] |
国家中医药管理局《中华本草》编委会. 中华本草[M]. 上海: 上海科学技术出版社, 1999: 338
|
[4] |
付钰. 中药大血藤对佐剂性关节炎大鼠血清TNF-α、IL-6的影响[J]. 现代医院, 2007, 7(9): 37-39. doi: 10.3969/j.issn.1671-332X.2007.09.020
|
[5] |
雷丽娟. 大血藤总酚及其抗类风湿性关节炎骨破坏作用研究[D]. 贵阳: 贵州大学, 2019.
|
[6] |
LIU D, LI P, SONG S, et al. Pro-apoptotic effect of epigallo-catechin-3-gallate on B lymphocytes through regulating BAFF/PI3K/Akt/mTOR signaling in rats with collagen-induced arthritis[J]. Eur J Pharmacol, 2012, 690(1/2/3): 214-225. http://www.sciencedirect.com/science/article/pii/S0014299912005389
|
[7] |
钱飞亚, 杨培, 张明菲, 等. 滋肾通络方对胶原性关节炎小鼠Th17/Treg细胞分化及平衡的影响[J]. 中国药理学通报, 2019, 35(5): 720-726. doi: 10.3969/j.issn.1001-1978.2019.05.025
|
[8] |
CHOUDHARY N, BHATT LK, PRABHAVALKAR KS. Experimental animal models for rheumatoid arthritis[J]. Immunopharmacol Immunotoxicol, 2018, 40(3): 193-200. doi: 10.1080/08923973.2018.1434793
|
[9] |
WONG BR, JOSIEN R, LEE SY, et al. TRANCE (tumor necrosis factor-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor[J]. J Exp Med, 1997, 186(12): 2075-2080. doi: 10.1084/jem.186.12.2075
|
[10] |
KARTSOGIANNIS V, ZHOU H, HORWOOD NJ, et al. Localization of RANKL (receptor activator of NF-κB ligand) mRNA and protein in skeletal and extraskeletal tissues[J]. Bone, 1999, 25(5): 525-534. doi: 10.1016/S8756-3282(99)00214-8
|
[11] |
WIELINSKA J, KOLOSSA K, SWIERKOT J, et al. Polymorphisms within the RANK and RANKL encoding genes in patients with rheumatoid arthritis: Association with disease progression and effectiveness of the biological treatment[J]. Arch Immunol Ther Exp, 2020, 68(4): 1-9. doi: 10.1007/s00005-020-00590-6
|
[12] |
HE Y, ZHANG Q, SHEN Y, et al. Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways[J]. Biochem Biophys Res Commun, 2014, 449(3): 344-350. doi: 10.1016/j.bbrc.2014.05.034
|
[13] |
ZHAO CM, GU YB, ZENG XY, et al. NLRP3 inflammasome regulates Th17 differentiation in rheumatoid arthritis[J]. Clin Immunol, 2018, 197: 154-160. doi: 10.1016/j.clim.2018.09.007
|
[14] |
LUO BB, HUANG F, LIU YL, et al. NLRP3 inflammasome as a molecular marker in diabetic cardiomyopathy[J]. Front Physiol, 2017, 8: 519. doi: 10.3389/fphys.2017.00519
|
[15] |
LIU DL, ZENG X, LI X, et al. Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases[J]. Basic Res Cardiol, 2018, 113(1): 5. doi: 10.1007/s00395-017-0663-9
|
[16] |
GUO C, FU R, WANG S, et al. NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis[J]. Clin Exp Immunol, 2018, 194(2): 231-243. doi: 10.1111/cei.13167
|
[17] |
DONG XW, ZHENG ZH, LIN P, et al. ACPAs promote IL-1β production in rheumatoid arthritis by activating the NLRP3 inflammasome[J]. Cell Mol Immunol, 2020, 17(3): 261-271. doi: 10.1038/s41423-019-0201-9
|